Your lifestyle also plays a huge part
Designed solely for parenteral use (drug administration by intravenous, intramuscular, or subcutaneous injection) following the addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injecting
CagriSema REDEFINE 2: Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
Khavinson VK, Diomede F, Mironova E, Linkova N, Trofimova S, Trubiani O, Caputi S, Sinjari B
2** CagriSema resulted in greater weight loss of 22.7% at 68 weeks versus 2.3% in the placebo group when evaluating the treatment effect if all patients stayed on treatment
Plasma levels decline with age, which is part of why it became a research target for skin, hair, and wound healing